The Targeted Sequencing and Resequencing Market is witnessing significant growth and is poised for substantial expansion in the forecast years. In 2022, the market size was valued at US$ 5.1 billion, and it is expected to grow at a robust CAGR of 21% from 2023 to 2029, reaching a market size of approximately US$ 19.3 billion by 2029.Targeted Sequencing and Resequencing Market Overview:
Advancements in sequencing technologies, the demand for personalized medicine, and the availability of genomics databases are expected to drive the market growth in forecast period and impact of each of these factor is analyzed in the report. With ongoing technological advancements and increasing applications in various sectors, the targeted sequencing and resequencing market is expected to witness substantial opportunities and play a pivotal role in advancing genomics research and healthcare practices.Targeted Sequencing and Resequencing Market Scope:
The report provides comprehensive analysis of the global targeted sequencing and resequencing market, covering the current market size, future growth prospects, key drivers, restraints, and opportunities influencing the market. It offers an in-depth analysis of the competitive landscape, market trends, and product innovations within the targeted sequencing and resequencing market. The scope of the report includes a detailed segmentation analysis of the market based on technology type, application, end-user, and region. The targeted sequencing and resequencing market serves a wide range of end-users, including academic research institutions, pharmaceutical and biotechnology companies, clinical research organizations, and diagnostic laboratories. These end-users utilize targeted sequencing and resequencing technologies for various applications, such as cancer profiling, genetic disease diagnosis, pharmacogenomics, and agricultural genomics. Sequencing and Resequencing Market Dynamics: Targeted sequencing and resequencing market is influenced by various drivers, restraints, opportunities, and trends. Understanding these dynamics is crucial for stakeholders in making informed decisions and capitalizing on market growth potential.To know about the Research Methodology :- Request Free Sample Report
Targeted Sequencing and Resequencing Market Drivers:
Targeted sequencing and resequencing techniques have gained significant growth in the life sciences and healthcare industry, The growing understanding of the role of genetics in various diseases, such as cancer, inherited disorders, and rare diseases, has fuelled the demand for targeted sequencing and resequencing. These techniques enable researchers to focus on specific regions of interest within the genome, allowing for a more detailed analysis of genetic variations. Rapid Technological Innovations: The development of high-throughput sequencing platforms and next-generation sequencing (NGS) technologies has revolutionized the field of genomics. These advancements have significantly reduced the cost per base and turnaround time, making targeted sequencing and resequencing more accessible and affordable for researchers and clinicians. Personalized Medicine: The emergence of personalized medicine, which aims to tailor treatments based on an individual's genetic makeup, has increased the demand for targeted sequencing and resequencing. These techniques provide valuable insights into an individual's genetic variants, allowing for more precise diagnosis, prognosis, and personalized treatment options.Targeted Sequencing and Resequencing Market Restraints:
Despite the positive market drivers, there are several restraints that can impact the growth of the targeted sequencing and resequencing market: High Initial Costs: The initial setup and infrastructure costs associated with targeted sequencing and resequencing can be substantial. The acquisition of sequencing instruments, data storage systems, and skilled personnel can pose financial challenges, particularly for small research institutions and clinics with limited budgets. Data Analysis and Interpretation Challenges: The generation of vast amounts of genomic data through targeted sequencing and resequencing creates a significant challenge in data analysis and interpretation. Efficient bioinformatics tools and expertise are required to process, analyse, and interpret the data accurately, which can be a bottleneck for many researchers and clinicians. Regulatory and Ethical Concerns: The use of targeted sequencing and resequencing techniques raises regulatory and ethical concerns related to data privacy, consent, and the responsible use of genomic information. Compliance with data protection regulations and the establishment of ethical guidelines are necessary for the wider adoption of these technologies.Targeted Sequencing and Resequencing Market Opportunities:
Targeted sequencing and resequencing techniques are expanding beyond research and diagnostics into areas such as agriculture, forensics, and infectious disease surveillance. The identification of genetic markers in crops, forensic DNA analysis, and tracking the transmission of infectious diseases offer new avenues for market growth. Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning (ML) algorithms with targeted sequencing and resequencing data analysis can enhance the accuracy and efficiency of variant calling, variant annotation, and interpretation of genomic data. The development of AI-powered bioinformatics tools holds promising opportunities in Targeted Sequencing and Resequencing Market for improving the overall workflow and decision-making process. Collaboration among academic institutions, research organizations, and industry players can accelerate advancements in targeted sequencing and resequencing technologies. Partnerships between sequencing platform manufacturers, bioinformatics software developers, and healthcare providers can drive innovation, improve accessibility, and foster the development of integrated solutions. Targeted Sequencing and Resequencing Market Trends: Single-Cell Sequencing: Single-cell sequencing techniques are gaining popularity as they enable the study of genomic heterogeneity within individual cells. Advancements in targeted single-cell sequencing technologies offer new insights into cellular dynamics, cancer genomics, and developmental biology, driving the demand for these techniques. Liquid Biopsy: The use of targeted sequencing and resequencing in liquid biopsies, which involve the analysis of circulating tumor DNA (ctDNA) and other biomarkers in blood samples, is gaining momentum.Targeted Sequencing and Resequencing Market Segment Analysis
The global targeted sequencing and resequencing market can be segmented based on product, application, geography, and end-user. By product, the market is categorized into instruments, reagents and consumables, and software and services. Instruments, such as sequencing platforms and sample preparation systems, are essential components for targeted sequencing and resequencing workflows. Reagents and consumables include various kits, enzymes, and buffers required for DNA sequencing reactions. Software and services encompass bioinformatics tools, data analysis platforms, and sequencing services that aid in the interpretation and analysis of genomic data. Based on application, the Targeted Sequencing and Resequencing Market can be segmented into oncology, genetic screening and testing, infectious diseases, agriculture and animal research, and others. Oncology represents a significant application area, as targeted sequencing and resequencing techniques are extensively used for the identification of cancer-related genetic mutations and personalized treatment approaches. Genetic screening and testing applications include prenatal testing, carrier screening, and diagnosis of inherited diseases. Infectious diseases, such as viral outbreaks, can be tracked and characterized using targeted sequencing. The agriculture and animal research segment utilizes targeted sequencing to identify genetic markers for crop improvement and livestock breeding. The end-user segment includes academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. Academic and research institutes play a crucial role in driving market growth, as they actively conduct genomic research and development. Pharmaceutical and biotechnology companies utilize targeted sequencing and resequencing for drug discovery, clinical trials, and precision medicine. Hospitals and clinics are increasingly adopting these techniques for diagnostic purposes and personalized treatment strategies.Targeted Sequencing and Resequencing Market Regional analysis:
The report provides a comprehensive analysis of the growth, trends, and opportunities in the Targeted Sequencing and Resequencing market across different regions. The market is segmented by region, product type, and end-use industry. North America dominates the Targeted Sequencing and Resequencing market, benefiting from major players, advanced research infrastructure, and a high demand for sequencing technologies in the genomics and healthcare industries. The region has well-established academic and research institutions, as well as a strong presence of pharmaceutical and biotechnology companies that drive the adoption of targeted sequencing and resequencing technologies. The region's focus on precision medicine, personalized genomics, and advancements in next-generation sequencing (NGS) technologies further contribute to the market growth in North America. Europe holds a significant Targeted Sequencing and Resequencing Market share, driven by its strong genomics research and development sector, well-established healthcare systems, and the presence of key market players. The region's emphasis on population-level genomics studies, genetic diagnostics, and the use of sequencing technologies in clinical applications fuels the demand for targeted sequencing and resequencing. Furthermore, the supportive regulatory framework, data protection policies, and collaborative initiatives for genomics research promote market growth in Europe. The Asia-Pacific region emerges as a rapidly growing market for Targeted Sequencing and Resequencing, driven by the increasing adoption of genomics technologies, rising investments in research and development, and the growing prevalence of genetic disorders. Countries like China, Japan, and India are witnessing significant growth in the use of sequencing technologies for personalized medicine, agriculture, and forensic applications. The region's large population, increasing healthcare expenditure, and government initiatives to promote genomics research and precision medicine contribute to the market growth in Asia-Pacific. Latin America and the Middle East and Africa experience moderate growth rates in the Targeted Sequencing and Resequencing market. These regions are gradually investing in genomics infrastructure, collaborating with international genomics projects, and adopting sequencing technologies for research and clinical applications. The increasing prevalence of genetic diseases, growing awareness about personalized medicine, and the need for improved healthcare services drive the adoption of targeted sequencing and resequencing in these regions. The global Targeted Sequencing and Resequencing industry presents diverse growth prospects, driven by the expanding genomics research and healthcare industries, increasing demand for personalized medicine and genetic diagnostics, and advancements in sequencing technologies across different regions. The market is expected to continue its growth trajectory as manufacturers focus on developing innovative and cost-effective sequencing platforms to meet the rising demand for accurate and efficient genetic analysis solution. Targeted Sequencing and Resequencing Market Competitive landscape: The report provides an analysis of the competitive landscape in the targeted sequencing and resequencing market, highlighting the key players and their strategies. Illumina Inc. emerges as a prominent company in this market, offering a wide range of next-generation sequencing (NGS) platforms and reagents, including targeted sequencing panels. Illumina's competitive edge lies in its continuous focus on technological innovation, investing heavily in research and development to enhance its sequencing technologies and develop novel applications. Another key strategy employed by Illumina is strategic collaborations with academic institutions and industry partners to expand its market presence and explore new opportunities. Thermo Fisher Scientific Inc. is also a major player in the targeted sequencing and resequencing market, providing comprehensive solutions for NGS applications. The company emphasizes the development of advanced sequencing platforms and reagents, including targeted sequencing kits. Thermo Fisher Scientific is committed to research and development activities, investing in innovative technologies to strengthen its product portfolio and improve sequencing accuracy and efficiency. Strategic acquisitions play a significant role in expanding Thermo Fisher Scientific's market reach and enhancing its capabilities in the targeted sequencing and resequencing space.Targeted Sequencing and Resequencing Market Scope: Inquire before buying
Targeted Sequencing and Resequencing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 5.1 Bn. Forecast Period 2023 to 2029 CAGR: 21% Market Size in 2029: US $ 19.3 Bn. Segments Covered: by Product Kits and Reagents Instruments Software and Services by Application Oncology Genetic Disorders Infectious Diseases Agricultural Research Others (Pharmacogenomics, Forensics, etc.) by End users Research Institutes and Academic Centres. Pharmaceutical and Biotechnology Companies Hospitals and Clinics Contract Research Organizations (CROs) Others (Forensic Labs, Government Agencies, etc.) Targeted Sequencing and Resequencing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Targeted Sequencing and Resequencing Market Key Players:
The report has in detail information about the Targeted Sequencing and Resequencing strategies adopted by the following key players to sustain and grow in the market. These players covered in the report are selected on the basis of certain criteria. 1. Illumina, Inc. (North America) 2. Thermo Fisher Scientific, Inc. (North America) 3. Pacific Biosciences of California, Inc. (North America) 4. Oxford Nanopore Technologies Ltd. (Europe) 5. Agilent Technologies, Inc. (North America) 6. Qiagen N.V. (Europe) 7. F. Hoffmann-La Roche Ltd (Europe) 8. PerkinElmer, Inc. (North America) 9. BGI Genomics Co., Ltd. (Asia-Pacific) 10. Genewiz (North America) 11. Eurofins Scientific (Europe) 12. Fluidigm Corporation (North America) 13. ZS Genetics, Inc. (North America) 14. ArcherDX, Inc. (North America) 15. 10x Genomics, Inc. (North America) 16. Swift Biosciences, Inc. (North America) 17. Macrogen, Inc. (Asia-Pacific) 18. GENEWIZ Germany GmbH (Europe) 19. Roche Sequencing Solutions, Inc. (North America) 20. PierianDx (North America) 21. MGI Tech Co., Ltd. (Asia-Pacific) 22. GATC Biotech AG (Europe) 23. Myriad Genetics, Inc. (North America) 24. Novogene Corporation (Asia-Pacific) 25. Agendia NV (Europe)Frequently Asked Questions:
1] What segments are covered in the Targeted Sequencing and Resequencing Market report? Ans. The segments covered in the market report are based on product type, type, application, end-user, and geography. 2] Which region is expected to hold the highest share in Targeted Sequencing and Resequencing Market? Ans. The North America region is expected to hold the highest share in market. 3] What is the market size of the Targeted Sequencing and Resequencing market by 2029? Ans. The market size of the market by 2029 is expected to reach US $ 19.3 billion. 4] What is the forecast period for the Targeted Sequencing and Resequencing Market? Ans. The Forecast period for the market is 2023-2029. 5] What was the market size of the Targeted Sequencing and Resequencing Market in 2023? Ans. The market size of market in 2022 was US $ 5.1 billion.
1. Targeted Sequencing and Resequencing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Targeted Sequencing and Resequencing Market: Dynamics 2.1. Targeted Sequencing and Resequencing Market Trends by Region 2.1.1. North America Targeted Sequencing and Resequencing Market Trends 2.1.2. Europe Targeted Sequencing and Resequencing Market Trends 2.1.3. Asia Pacific Targeted Sequencing and Resequencing Market Trends 2.1.4. Middle East and Africa Targeted Sequencing and Resequencing Market Trends 2.1.5. South America Targeted Sequencing and Resequencing Market Trends 2.2. Targeted Sequencing and Resequencing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Targeted Sequencing and Resequencing Market Drivers 2.2.1.2. North America Targeted Sequencing and Resequencing Market Restraints 2.2.1.3. North America Targeted Sequencing and Resequencing Market Opportunities 2.2.1.4. North America Targeted Sequencing and Resequencing Market Challenges 2.2.2. Europe 2.2.2.1. Europe Targeted Sequencing and Resequencing Market Drivers 2.2.2.2. Europe Targeted Sequencing and Resequencing Market Restraints 2.2.2.3. Europe Targeted Sequencing and Resequencing Market Opportunities 2.2.2.4. Europe Targeted Sequencing and Resequencing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Targeted Sequencing and Resequencing Market Drivers 2.2.3.2. Asia Pacific Targeted Sequencing and Resequencing Market Restraints 2.2.3.3. Asia Pacific Targeted Sequencing and Resequencing Market Opportunities 2.2.3.4. Asia Pacific Targeted Sequencing and Resequencing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Targeted Sequencing and Resequencing Market Drivers 2.2.4.2. Middle East and Africa Targeted Sequencing and Resequencing Market Restraints 2.2.4.3. Middle East and Africa Targeted Sequencing and Resequencing Market Opportunities 2.2.4.4. Middle East and Africa Targeted Sequencing and Resequencing Market Challenges 2.2.5. South America 2.2.5.1. South America Targeted Sequencing and Resequencing Market Drivers 2.2.5.2. South America Targeted Sequencing and Resequencing Market Restraints 2.2.5.3. South America Targeted Sequencing and Resequencing Market Opportunities 2.2.5.4. South America Targeted Sequencing and Resequencing Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Targeted Sequencing and Resequencing Industry 2.8. Analysis of Government Schemes and Initiatives For Targeted Sequencing and Resequencing Industry 2.9. Targeted Sequencing and Resequencing Market Trade Analysis 2.10. The Global Pandemic Impact on Targeted Sequencing and Resequencing Market 3. Targeted Sequencing and Resequencing Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 3.1.1. Kits and Reagents 3.1.2. Instruments 3.1.3. Software and Services 3.2. Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 3.2.1. Oncology 3.2.2. Genetic Disorders 3.2.3. Infectious Diseases 3.2.4. Agricultural Research 3.2.5. Others (Pharmacogenomics, Forensics, etc.) 3.3. Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 3.3.1. Research Institutes and Academic Centres. 3.3.2. Pharmaceutical and Biotechnology Companies 3.3.3. Hospitals and Clinics 3.3.4. Contract Research Organizations (CROs) 3.3.5. Others (Forensic Labs, Government Agencies, etc.) 3.4. Targeted Sequencing and Resequencing Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Targeted Sequencing and Resequencing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 4.1.1. Kits and Reagents 4.1.2. Instruments 4.1.3. Software and Services 4.2. North America Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 4.2.1. Oncology 4.2.2. Genetic Disorders 4.2.3. Infectious Diseases 4.2.4. Agricultural Research 4.2.5. Others (Pharmacogenomics, Forensics, etc.) 4.3. North America Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 4.3.1. Research Institutes and Academic Centres. 4.3.2. Pharmaceutical and Biotechnology Companies 4.3.3. Hospitals and Clinics 4.3.4. Contract Research Organizations (CROs) 4.3.5. Others (Forensic Labs, Government Agencies, etc.) 4.4. North America Targeted Sequencing and Resequencing Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 4.4.1.1.1. Kits and Reagents 4.4.1.1.2. Instruments 4.4.1.1.3. Software and Services 4.4.1.2. United States Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 4.4.1.2.1. Oncology 4.4.1.2.2. Genetic Disorders 4.4.1.2.3. Infectious Diseases 4.4.1.2.4. Agricultural Research 4.4.1.2.5. Others (Pharmacogenomics, Forensics, etc.) 4.4.1.3. United States Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 4.4.1.3.1. Research Institutes and Academic Centres. 4.4.1.3.2. Pharmaceutical and Biotechnology Companies 4.4.1.3.3. Hospitals and Clinics 4.4.1.3.4. Contract Research Organizations (CROs) 4.4.1.3.5. Others (Forensic Labs, Government Agencies, etc.) 4.4.2. Canada 4.4.2.1. Canada Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 4.4.2.1.1. Kits and Reagents 4.4.2.1.2. Instruments 4.4.2.1.3. Software and Services 4.4.2.2. Canada Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 4.4.2.2.1. Oncology 4.4.2.2.2. Genetic Disorders 4.4.2.2.3. Infectious Diseases 4.4.2.2.4. Agricultural Research 4.4.2.2.5. Others (Pharmacogenomics, Forensics, etc.) 4.4.2.3. Canada Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 4.4.2.3.1. Research Institutes and Academic Centres. 4.4.2.3.2. Pharmaceutical and Biotechnology Companies 4.4.2.3.3. Hospitals and Clinics 4.4.2.3.4. Contract Research Organizations (CROs) 4.4.2.3.5. Others (Forensic Labs, Government Agencies, etc.) 4.4.3. Mexico 4.4.3.1. Mexico Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 4.4.3.1.1. Kits and Reagents 4.4.3.1.2. Instruments 4.4.3.1.3. Software and Services 4.4.3.2. Mexico Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 4.4.3.2.1. Oncology 4.4.3.2.2. Genetic Disorders 4.4.3.2.3. Infectious Diseases 4.4.3.2.4. Agricultural Research 4.4.3.2.5. Others (Pharmacogenomics, Forensics, etc.) 4.4.3.3. Mexico Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 4.4.3.3.1. Research Institutes and Academic Centres. 4.4.3.3.2. Pharmaceutical and Biotechnology Companies 4.4.3.3.3. Hospitals and Clinics 4.4.3.3.4. Contract Research Organizations (CROs) 4.4.3.3.5. Others (Forensic Labs, Government Agencies, etc.) 5. Europe Targeted Sequencing and Resequencing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.2. Europe Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.3. Europe Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 5.4. Europe Targeted Sequencing and Resequencing Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.1.2. United Kingdom Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.1.3. United Kingdom Targeted Sequencing and Resequencing Market Size and Forecast, by End users(2022-2029) 5.4.2. France 5.4.2.1. France Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.2.2. France Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.2.3. France Targeted Sequencing and Resequencing Market Size and Forecast, by End users(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.3.2. Germany Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.3.3. Germany Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.4.2. Italy Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.4.3. Italy Targeted Sequencing and Resequencing Market Size and Forecast, by End users(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.5.2. Spain Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.5.3. Spain Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.6.2. Sweden Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.6.3. Sweden Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.7.2. Austria Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.7.3. Austria Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 5.4.8.2. Rest of Europe Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 5.4.8.3. Rest of Europe Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6. Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.2. Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.3. Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4. Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.1.2. China Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.1.3. China Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.2.2. S Korea Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.2.3. S Korea Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.3.2. Japan Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.3.3. Japan Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.4. India 6.4.4.1. India Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.4.2. India Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.4.3. India Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.5.2. Australia Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.5.3. Australia Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.6.2. Indonesia Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.6.3. Indonesia Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.7.2. Malaysia Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.7.3. Malaysia Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.8.2. Vietnam Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.8.3. Vietnam Targeted Sequencing and Resequencing Market Size and Forecast, by End users(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.9.2. Taiwan Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.9.3. Taiwan Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 6.4.10.2. Rest of Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 6.4.10.3. Rest of Asia Pacific Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 7. Middle East and Africa Targeted Sequencing and Resequencing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 7.2. Middle East and Africa Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 7.3. Middle East and Africa Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 7.4. Middle East and Africa Targeted Sequencing and Resequencing Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 7.4.1.2. South Africa Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 7.4.1.3. South Africa Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 7.4.2.2. GCC Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 7.4.2.3. GCC Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 7.4.3.2. Nigeria Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 7.4.3.3. Nigeria Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 7.4.4.2. Rest of ME&A Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 7.4.4.3. Rest of ME&A Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 8. South America Targeted Sequencing and Resequencing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 8.2. South America Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 8.3. South America Targeted Sequencing and Resequencing Market Size and Forecast, by End users(2022-2029) 8.4. South America Targeted Sequencing and Resequencing Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 8.4.1.2. Brazil Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 8.4.1.3. Brazil Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 8.4.2.2. Argentina Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 8.4.2.3. Argentina Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Targeted Sequencing and Resequencing Market Size and Forecast, by Product (2022-2029) 8.4.3.2. Rest Of South America Targeted Sequencing and Resequencing Market Size and Forecast, by Application (2022-2029) 8.4.3.3. Rest Of South America Targeted Sequencing and Resequencing Market Size and Forecast, by End users (2022-2029) 9. Global Targeted Sequencing and Resequencing Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Targeted Sequencing and Resequencing Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Illumina, Inc. (North America) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Thermo Fisher Scientific, Inc. (North America) 10.3. Pacific Biosciences of California, Inc. (North America) 10.4. Oxford Nanopore Technologies Ltd. (Europe) 10.5. Agilent Technologies, Inc. (North America) 10.6. Qiagen N.V. (Europe) 10.7. F. Hoffmann-La Roche Ltd (Europe) 10.8. PerkinElmer, Inc. (North America) 10.9. BGI Genomics Co., Ltd. (Asia-Pacific) 10.10. Genewiz (North America) 10.11. Eurofins Scientific (Europe) 10.12. Fluidigm Corporation (North America) 10.13. ZS Genetics, Inc. (North America) 10.14. ArcherDX, Inc. (North America) 10.15. 10x Genomics, Inc. (North America) 10.16. Swift Biosciences, Inc. (North America) 10.17. Macrogen, Inc. (Asia-Pacific) 10.18. GENEWIZ Germany GmbH (Europe) 10.19. Roche Sequencing Solutions, Inc. (North America) 10.20. PierianDx (North America) 10.21. MGI Tech Co., Ltd. (Asia-Pacific) 10.22. GATC Biotech AG (Europe) 10.23. Myriad Genetics, Inc. (North America) 10.24. Novogene Corporation (Asia-Pacific) 10.25. Agendia NV (Europe) 11. Key Findings 12. Industry Recommendations 13. Targeted Sequencing and Resequencing Market: Research Methodology 14. Terms and Glossary